Dr. Westerhout oversees the CVC Clinical Trial Statistics team, and provides consultation on the design and analysis of clinical trials and observational studies. She also advises the directors, faculty and management team on the strategic directions of the CVC, and leads strategy implementation. Her research interests include therapeutic treatment effects (e.g., composite endpoints) in randomized clinical trials.
Dr. Westerhout completed a MSc in epidemiology at the University of Alberta in 2001 and a PhD in clinical cardiovascular epidemiology at Erasmus University (Rotterdam, the Netherlands) in 2007. She is currently a member of the editorial board of the American Heart Journal, and is a co-founder of the BALSAM (Biomedical AnaLytics Studio And Methods unit) at the University of Alberta.
